Updated · 2 episodes · 1 show · 2 source notes

concept

Science Funding Portfolio Logic

Definition

Science funding portfolio logic is the episode’s view that federal research funding should tolerate more variance in method, duration, and risk so that a few major breakthroughs can justify many failed or unproductive bets.

Current Synthesis

The Kratsios and Weinstein interviews both import a portfolio intuition into public science funding without saying government research should become ordinary venture capital. Kratsios emphasizes controlled experiments in selection rights, grant duration, and recipient autonomy. Weinstein supplies the more radical high-beta version: fund serious people and questions that consensus institutions dislike when the upside is large enough, because breakthrough science is harmed by systems optimized for predictable output.

Key Claims

  • Meta-science units should experimentally compare funding models rather than assume current grant processes are optimal.
  • Reviewer “golden tickets” are meant to let individual expert conviction fund some projects that committee consensus might miss.
  • Grant duration should vary because some research needs rapid seed funding while other work needs three to five years of patient support.
  • Portable fellowships represent a people-first mechanism because talented scientists can choose the institution that best supports their work.
  • High-upside basic science may justify low-probability bets when the payoff is large enough and the investigator is credible.
  • The portfolio logic remains public-science logic: the goal is breakthrough discovery and scientific output, not private financial return.

Evidence

Counterevidence & Qualifications

The sources present the logic as policy argument and expert diagnosis, not as measured proof that alternative grant designs will outperform ordinary peer review. Golden-ticket or high-beta funding could surface neglected ideas, but it could also concentrate discretion, reward charisma, or fund weak contrarianism unless evaluation, conflict controls, and outcome tracking are credible.

What Changed

  • Added Weinstein’s high-beta version of the portfolio argument beside Kratsios’s grant-mechanism version.
  • Reframed the concept around variance tolerance, credible person selection, and public accountability.

Sources

2 source notes across 1 show
  1. Michael Kratsios: Trump's Science Agenda, Anti-Science Claims, Fauci's Damage, DEI & China All-In with Chamath, Jason, Sacks & Friedberg
  2. Eric Weinstein: The State of American Science, Breakthrough Coverups, and the Danger of Physics All-In with Chamath, Jason, Sacks & Friedberg